(Q53356778)

English

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

author name string

E Gane

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

F Saliba

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

G J Valdecasas

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

J O'Grady

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

M D Pescovitz

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

S Lyman

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

C A Robinson

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

350

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

9093

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

1729-1733

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical patterns of cytomegalovirus disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Donated organ as a source of cytomegalovirus in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost impact of cytomegalovirus disease in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905535-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)05535-9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/9413463

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53356778&oldid=2104965270"